Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

COMT inhibitor increases response to L-DOPA in patients with PD

June 6, 1997

Alpha2-antagonist effective in patients with Parkinson's disease

June 6, 1997

Promising animal data reported for Mitsui Toatsu cerebroprotectant

June 6, 1997

Olanzapine superior to haloperidol against negative symptoms in schizophrenia

June 6, 1997

Body weight positively correlated with cognitive performance in AD

June 6, 1997

FDA approves generic version of Diamox

June 6, 1997

Antiamnesic effects of RU-47231 in rats

June 5, 1997

Transgenic mouse model of AD developed by Canadian researchers

June 5, 1997

Pfizer sponsors Canadian study of drug treatment in later stages of AD

June 5, 1997

Efficacy of chronic treatment with tolcapone + levodopa in Parkinson's disease

June 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...